Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Two doses of either the Pfizer or Oxford-AstraZeneca vaccine offer similar protection against symptomatic SARS-CoV-2 infection to that coming from natural immunity after infection, an ongoing study of healthcare workers has found.

OUH’s Chief Nurse, Sam Foster, delivers a Pfizer vaccine to a member of staff

None of the 1,456 healthcare workers at Oxford University Hospitals (OUH) NHS Foundation Trust who had received two vaccines had a symptomatic infection when followed up more than 14 days after their second vaccination. The same high level of protection was seen in unvaccinated healthcare workers who had contracted COVID-19 naturally; they had 98% fewer symptomatic infections than unvaccinated individuals who had not been infected before.

Most of the healthcare workers studied had only received one vaccine to date. Protection against symptomatic infection was lower – at 67% – after a first dose of vaccine – received by 11,023 hospital staff.

The findings were the latest data from ongoing analysis of symptomatic and asymptomatic staff testing for SARS-CoV-2 at OUH’s four hospitals and associated facilities. In total, 13,109 healthcare workers have participated.

Of these, 8,285 have received the Pfizer-BioNTech vaccine (1,407 of them two doses) and 2,738 the Oxford-AstraZeneca vaccine (49 of them receiving both doses).

Read the full story on the NIHR Oxford Biomedical Research Centre website

Similar stories

NHS garden in full bloom at RHS Chelsea Flower Show

The sun was shining for the RHS Chelsea Flower show press day earlier this week. One garden in particular bloomed particularly brightly, with the 'Finding Our Way: An NHS Tribute Garden' getting plenty of attention.

University of Oxford launches Podium Analytics Institute for Youth Sports Medicine and Technology

Oxford University has been selected as the home of the new Podium Analytics Institute for Youth Sports Medicine and Technology. This will be the world’s first academic Institute focused on young athletes’ safety and lifelong health and will combine Oxford’s longstanding tradition in sports and education with the very best of science, medicine, and technology.

QCovid highly commended for ‘best use of technology in Patient Safety’ at the 2021 HSJ Patient Safety Awards

Professor Julia Hippisley-Cox and her team in Nuffield Department of Primary Care Health Sciences have been Highly Commended in the ‘Best use of technology in Patient Safety’ category for the QCovid risk calculator at this year’s Health Service Journal Patient Safety Awards.

New guidelines to improve reporting standards of studies that investigate causal mechanisms

Researchers in the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) have developed a new set of guidelines for reporting mediation analyses in health research.

Prestigious award for Oxford professor's diabetes work

A University of Oxford professor has been awarded the 2021 EASD-Novo Nordisk Foundation Prize for Excellence for his decades of effort to understand, prevent and combat type 1 diabetes.